Sabra Health Care REIT, Inc. to Participate in Non-Deal Roadshow

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 9/26/2026

1. SPY
2. AKAM
3. COST
4. META
5. ZS

6. NVDA
7. AWK
8. DRI
9. ULS
10. PRME

Get Alerts SBRA Hot Sheet

Price: $19.85 +0.40%

Overall Analyst Rating:
SELL (= Flat)

Dividend Yield: 9.4%
Revenue Growth %: +22.4%

Join SI Premium – FREE

IRVINE, Calif., Nov. 29, 2017 (GLOBE NEWSWIRE) -- Sabra Health Care REIT, Inc. (Nasdaq: SBRA) (Nasdaq: SBRAP) announced today that Rick Matros, the company’s Chairman and Chief Executive Officer, Harold Andrews, the company’s Chief Financial Officer, and Talya Nevo-Hacohen, the company’s Chief Investment Officer, will participate in a non-deal roadshow hosted by JMP Securities on December 11-13, 2017 in New York, NY and Boston, MA.

About Sabra

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) (Nasdaq: SBRAP), a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Sabra leases properties to tenants and operators throughout the United States and Canada.

CONTACT:

Investor & Media Inquiries: 1-888-393-8248 or [email protected]